(Q44186907)

30 November 2017

title

Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2 (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

5 December 2022

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

5 December 2022

P. Lissoni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

5 December 2022

E. Tisi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

5 December 2022

F. Brivio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

5 December 2022

S. Barni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

5 December 2022

F. Rovelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

5 December 2022

M. Perego

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

5 December 2022

G. Tancini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1832885

5 December 2022

publication date

1 January 1991

1 reference

full work available at URL

30 November 2017

https://api.elsevier.com/content/article/PII:027753799190271E?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

https://api.elsevier.com/content/article/PII:027753799190271E?httpAccept=text/plain

5 December 2022

1 reference

Crossref

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

European Journal of Cancer

5 December 2022

published in

1 reference

30 November 2017

1 reference

30 November 2017

1 reference

30 November 2017

page(s)

1014-1016

1 reference

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

Recombinant interleukin-2 by continuous infusion and adoptive transfer of recombinant interleukin-2-activated cells in patients with advanced cancer

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

Suppressor Cells in Neoplastic Disease

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

Suppression of cell-mediated tumour immunity by Corynebacterium parvum

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

5 December 2022

Identifiers

1 reference

30 November 2017

1 reference